The Penn Center for Innovation announces two key appointments to expand and enhance institution-wide innovation and technology commercialization activities

The Penn Center for Innovation (PCI) has announced two key appointments to support the next phase of its comprehensive innovation and commercialization plan.

Featured Technology: Penn Medicine AInSights Technology 

Penn Medicine's AInSights is a cloud-based machine learning platform accessible by clinicians for real-time image analysis supporting multiple machine learning algorithms.

Y-Prize Goes to LilyLoop, a feminine product that captures menstrual flow data for improved diagnostics

LilyLoop, which proposed a commercial application for Penn’s biodegradeable moisture sensors, is the winner of the Mack Institute for Innovation Management’s 2024 Y-Prize Competition. 

PCIV Company OmnicPath AI Published in Nature BioTechnology

OmnicPath AI specializes in developing an end-to-end workflow that integrates Spatial Transcriptomics (ST) data and high-resolution histology images to predict spatial gene expression.

The Future Applications of Penn Medicine’s mRNA Technology 

Weissman has partnered in building 18 mRNA-capable Good Manufacturing Practice (GMP) sites to date across the world.

Koo and Steager’s Tooth-brushing microrobots offer even more life-changing applications 

In 2024, Koo and Steager sat down with Penn Today to discuss this technology’s potential not only to brush teeth, but also to diagnose and treat infectious diseases–in teeth and beyond. 

Shu Yang’s Research Highlighted in Penn Today 

In this Penn Today article, Yang explains how her inventions begin with changes on a fundamental level that can then grow into scalable and impactful products.

The Philadelphia Business Journal Showcases Robotics Growth in Philadelphia 

The Philadelphia Business Journal recently released an article about robotics growth in Philadelphia.

Penn Spinout EpiVario Announces Acquisition of Acetyl CoA Synthetase 2 (ACSS2) Inhibitor Portfolio from Metabomed LTD

Penn spinout EpiVario, a biotech company focusing on neuroepigenetics for addiction disorders, has acquired small molecule acetyl co-A synthetase-2 inhibitor (ACSS2i) portfolio.

Four Penn Startups Make The Philadelphia Business Journal’s PHL Inno List of 2024 Startups to Watch 

Baleena, BlueWhale Bio, Treeswift and Verismo were all recognized.

Filter

Success Stories

Highlights of the PCI news focused on Penn commercialization accomplishments

All Success Stories
Skip to content